Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9.40%585.31M | -30.08%931.96M | -28.62%535.01M | -16.64%1.33B | -3.57%1.11B | 25.63%749.51M | 35.17%319.92M | 6.78%1.6B | -3.49%1.15B | -26.22%596.62M |
| Operating income | 9.40%585.31M | -30.08%931.96M | -28.62%535.01M | -16.64%1.33B | -3.57%1.11B | 25.63%749.51M | 35.17%319.92M | 6.78%1.6B | -3.49%1.15B | -26.22%596.62M |
| Cost of sales | -1.30%-383.33M | 33.59%-668.63M | 29.91%-378.42M | 18.38%-1.01B | 0.15%-844.68M | -34.37%-539.9M | -39.03%-223.22M | -6.79%-1.23B | 7.43%-845.93M | 35.94%-401.79M |
| Other costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---257.79M | ---- | ---- |
| Operating expenses | -1.30%-383.33M | 33.59%-668.63M | 29.91%-378.42M | 32.49%-1.01B | 0.15%-844.68M | -34.37%-539.9M | -39.03%-223.22M | -29.11%-1.49B | 7.43%-845.93M | 35.94%-401.79M |
| Gross profit | 28.99%201.97M | -19.21%263.33M | -25.30%156.59M | 203.27%325.96M | -13.11%263.17M | 7.59%209.61M | 27.02%96.7M | -68.59%107.48M | 9.57%302.88M | 7.34%194.82M |
| Selling expenses | 34.78%-16.66M | 20.99%-45.47M | 9.76%-25.54M | 5.83%-57.55M | 0.06%-43.93M | -6.21%-28.3M | -33.82%-16.37M | -7.82%-61.11M | -126.59%-43.96M | -122.22%-26.64M |
| Administrative expenses | -9.27%-77.59M | -2.43%-132.12M | -13.35%-71.01M | 1.01%-128.99M | 0.58%-97.5M | 6.32%-62.64M | 7.60%-29.81M | 15.99%-130.31M | 25.52%-98.07M | 26.96%-66.87M |
| Impairment and provision | ---- | -132.86%-2.84M | ---- | 391.67%8.65M | ---- | ---- | ---- | 57.54%-2.96M | ---- | ---- |
| -Other impairment is provision | ---- | -132.86%-2.84M | ---- | 391.67%8.65M | ---- | ---- | ---- | 57.54%-2.96M | ---- | ---- |
| Special items of operating profit | -321.58%-28.47M | 937.92%26.87M | 279.69%12.85M | -117.00%-3.21M | 45.60%7.2M | -183.27%-7.15M | -271.95%-6.82M | 161.71%18.87M | 173.01%4.95M | 757.50%8.59M |
| Operating profit | 8.75%79.26M | -24.22%109.78M | -34.64%72.89M | 312.93%144.86M | -22.23%128.94M | 1.47%111.52M | 22.78%43.7M | -152.09%-68.03M | 37.42%165.79M | 56.74%109.9M |
| Financing income | 8.78%694K | 13.47%1.15M | 18.37%638K | 130.59%1.01M | 479.59%568K | 557.32%539K | 322.22%76K | 338.00%438K | 36.11%98K | 41.38%82K |
| Financing cost | 16.62%-8.2M | 4.71%-18.67M | 2.22%-9.84M | -32.49%-19.59M | -45.19%-14.98M | -54.98%-10.06M | -67.65%-4.96M | -19.72%-14.79M | -9.97%-10.31M | -1.74%-6.49M |
| Earning before tax | 12.66%71.76M | -26.94%92.26M | -37.56%63.69M | 253.29%126.28M | -26.38%114.54M | -1.44%102M | 18.88%38.82M | -169.61%-82.38M | 39.73%155.58M | 62.23%103.49M |
| Tax | 7.72%-23.06M | -90.71%-67.98M | 1.66%-24.99M | -1,932.54%-35.64M | 28.42%-31.04M | 15.46%-25.41M | -10.52%-9.93M | 104.99%1.95M | -42.73%-43.36M | -75.44%-30.06M |
| After-tax profit from continuing operations | 25.83%48.7M | -73.21%24.28M | -49.47%38.7M | 212.68%90.64M | -25.59%83.5M | 4.30%76.59M | 22.05%28.9M | -201.30%-80.44M | 38.61%112.22M | 57.38%73.43M |
| Earning after tax | 25.83%48.7M | -73.21%24.28M | -49.47%38.7M | 212.68%90.64M | -25.59%83.5M | 4.30%76.59M | 22.05%28.9M | -201.30%-80.44M | 38.61%112.22M | 57.38%73.43M |
| Profit attributable to shareholders | 25.83%48.7M | -73.21%24.28M | -49.47%38.7M | 212.68%90.64M | -25.59%83.5M | 4.30%76.59M | 22.05%28.9M | -201.30%-80.44M | 38.61%112.22M | 57.38%73.43M |
| Basic earnings per share | 25.84%0.0487 | -73.18%0.0243 | -49.48%0.0387 | 212.69%0.0906 | -25.58%0.0835 | 4.36%0.0766 | 21.94%0.0289 | -201.26%-0.0804 | 38.52%0.1122 | 57.17%0.0734 |
| Diluted earnings per share | 25.84%0.0487 | -73.18%0.0243 | -49.48%0.0387 | 212.69%0.0906 | -25.58%0.0835 | 4.36%0.0766 | 21.94%0.0289 | -201.26%-0.0804 | 38.52%0.1122 | 57.17%0.0734 |
| Currency Unit | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.